Intravitreal administration of nanomedicines could be valuable for retinal gene therapy, if their mobility in the vitreous and therapeutic efficacy in the target cells can be guaranteed. Hyaluronic acid (HA) as an electrostatic coating of polymeric gene nanomedicines has proven to be beneficial on both accounts. While electrostatic coating provides an easy way of coating cationic nanoparticles, the stability of electrostatic complexes in vivo is uncertain. In this study, therefore, we compare electrostatic with covalent coating of gene nanocarriers with HA for retinal gene therapy via intravitreal administration. Specifically, DOTAP:DOPE/plasmid DNA lipoplexes coated with HA are evaluated in terms of intravitreal mobility using a previously optimized ex vivo model. We find that both electrostatic and covalent HA coating considerably improve the mobility of the lipoplexes in the vitreous humor of excised bovine eyes. In addition we evaluate in vitro uptake and transfection efficiency in ARPE-19 cells. Contrary to PEGylated lipoplexes it is found that HA coated lipoplexes are efficiently internalized into ARPE-19 cells. Covalent HA-coated lipoplexes had an 8-fold increase of transgene expression compared to the uncoated lipoplexes. We conclude that covalent HA-coating of gene nanomedicines is a promising approach for retinal gene therapy by intravitreal administration.
Introduction
A wide variety of retinal disorders, often leading to blindness or severely affecting vision, are potential therapeutic targets for retinal gene therapy (Trapani et al., 2014) . While most clinical successes have been achieved by subretinal injection of viral vectors, this procedure is very invasive and requires the expertise of vitreoretinal surgeons, limiting its application on a large scale. Due to the local retinal detachment induced during the injection, photoreceptor cell death can occur, resulting in a loss of visual function (Zulliger et al., 2015) . In addition, even though viral vectors reach high transfection efficiencies in vivo, gene expression is usually limited to the immediate surroundings of the injection site (Igarashi et al., 2013) . Furthermore, viral vectors are expensive to produce, and are associated with potential immunogenic reactions and neurotropic dissemination (Kumar-Singh, 2008; Provost et al., 2005) . In light of this, intravitreal injection of non-viral vectors could be a more suitable alternative for the delivery of therapeutic nucleic acids (NAs) to the retina. (Adijanto and Naash, 2015) Intravitreal injection of therapeutics is nowadays being performed on a daily basis in the clinic such as for the treatment of wet AMD with anti-VEGF medication like Lucentis®. In contrast to subretinal injection, it can be performed by trained personnel with barely any post-injection complications (Englander et al., 2013) . Even though intravitreal injection has been associated with increased ocular pressure (IOP) and a small risk of endophthalmitis, these risks can be easily managed and cannot be compared to the risks of other intraocular administration routes. Furthermore, non-viral vectors offer several advantages over viral vectors, being (i) cheaper to produce on a large scale, (ii) less immunogenic and (iii) higher cargo capacity (Issa and MacLaren, 2012) . Especially the latter is important for gene therapy as some hereditary disorders require delivery of a therapeutic gene larger than the cargo capacity of AAV vectors (e.g. ABCA4 for Stargardt syndrome). Typically, non-viral vectors lack the transfection efficiency of their viral counterparts, nor can they bring about stable transfection. Nonetheless, efficient delivery routes could aid in increasing the transfection efficiency of non-viral vectors at the target site.
There is an immense variety of non-viral vectors, differing in composition and surface features. They can be subdivided in two major classes, being polymeric and lipid nanocarriers (Koirala et al., 2013) . Both types of nanocarriers usually have a positive charge, which allows them to spontaneously complex with anionic NAs. This results in the formation of spherical particles with sizes ranging around 100 nm to 500 nm with versatile surface characteristics depending on the functionalization of the non-viral vector used (Remaut et al., 2007) . We, and others, have previously shown that intravitreally injected nanoparticles can be hampered en route to the retina by the vitreous humor itself. Especially cationic charges and hydrophobicity were shown to be detrimental for intravitreal mobility (Kim et al., 2009; Martens et al., 2013; Peeters et al., 2005; Pitkänen et al., 2003; Xu et al., 2013) . We demonstrated that this impaired mobility can be alleviated by surface decoration with polyethylene glycol (PEGylation), though it is also known to be detrimental for cellular interactions (Mishra et al., 2004; Sanders et al., 2007) . With the aim to combine optimal vitreal mobility with efficient retinal cell uptake, we have previously proposed to use hyaluronic acid (HA) as an alternative coating strategy for PEG (Martens et al., 2015) .
HA is a glycosaminoglycan ubiquitously found in mammals and is a major macromolecular component of the vitreous humor. In recent years, its use in drug delivery has surged due to its biocompatible and non-immunogenic nature, combined with its inherent anionic and viscoelastic properties (Raemdonck et al., 2013) . HA molecules have several sites appropriate for chemical modification (e.g. hydroxyl, carboxyl, N-acetyl) which adds to its attractiveness for use in drug delivery. Since HA is a ligand for various cell receptors, most notably CD44, HAconjugation is abundantly investigated for drug targeting to CD44-overexpressing (tumor) tissues (Arpicco et al., 2013) . Also in the field of ocular drug delivery, HA is gaining attention as a drug delivery additive (Apaolaza et al., 2016 (Apaolaza et al., , 2014 Gan et al., 2013; Koo et al., 2012; Martens et al., 2015) . Indeed, we have previously shown that an electrostatic coating of HA was able to increase intravitreal mobility of cationic polymeric gene complexes while maintaining cellular uptake and transfection efficiency (Martens et al., 2015) . Also in other recent reports electrostatic HA-coating has been found to improve in vitro transfection efficiency of gene polyplexes in various retinal cell types (Apaolaza et al., 2014; Ruiz De Garibay et al., 2015) . However, electrostatic coating of HA may be unstable in contact with extracellular matrices or tissues. It is therefore of interest to evaluate covalent HA coating as a more stable alternative to the electrostatic coating for retinal gene therapy via intravitreal administration.
In the present study, we prepared electrostatic and covalent HAcoated lipid gene nanomedicines and compared their performance in terms of vitreal mobility and capacity to transfect retinal cells in vitro. Lipid gene nanomedicines containing plasmid DNA (pDNA) were composed of the cationic lipid 1,2-Dioleoyl-3-trimethylammonium-propane (DOTAP) and the fusogenic lipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). Intravitreal mobility of both HA-coated lipoplexes was evaluated using our previously published ex vivo eye model, using cadaveric bovine eyes and single particle tracking microscopy . Cellular uptake and transfection was evaluated in an in vitro ARPE-19 cell line, representative for the retinal pigment epithelium (RPE) cell layer (Strauss, 2005) .
Materials and methods

Materials
Dulbecco's modified Eagle's medium supplemented with nutrient mixture F12 (DMEM:F12 (1:1), OptiMEM™, Trypan Blue, L-glutamine, fetal bovine serum (FBS), penicillin-streptomycin solution (5000 IU/mL penicillin and 5000 μg/mL streptomycin) (P/S), and Dulbecco's phosphate-buffered saline (DPBS 1 ×, with or without Ca 2+ /Mg 2+ ) were supplied by GibcoBRL (Merelbeke, Belgium). 1,2-Dioleoyl-3-trimethylammonium-propane (DOTAP) chloride salt was obtained from Avanti Polar Lipids (Alabaster, AL, USA), 1,2-dioleoylsn-glycero-3-phosphoethanolamine (DOPE) from Lipoid GmbH (Ludwigshafen, Germany), 1-ethyl-3-[3-dimethyl) aminopropyl] carbodiimide hydrochloride (EDC) from Sigma-Aldrich (Saint-Quentin Fallavier, France) and high-molecular-weight HA (1,600,000 Da) from Fluka (Sigma-Aldrich Chemie, Buchs, Switzerland). All other reagents were purchased from Sigma-Aldrich (Bornem, Belgium), unless otherwise stated.
Plasmids
The plasmid constructs pGL4.13 (4641 bp) and gwiz-GFP (5757 bp) (Promega, Leiden, The Netherlands) were amplified in transformed E. coli bacteria and isolated from a bacteria suspension with a Purelink™ HiPure Plasmid DNA Gigaprep kit K2100 (Invitrogen, Merelbeke, Belgium). Concentration and purity were determined by UV absorption at 260 nm and 280 nm on a NanoDrop 2000c (Thermo Fisher Scientific, Rockford, IL, USA). Finally, the plasmids were suspended at a concentration of 1 μg/μL and stored in 25 mM HEPES, pH 7.2, at −20°C. For fluorescent labeling of pGL4.13 plasmids with YOYO-1™ (λ ex = 491 nm, λ em = 509 nm, Molecular Probes, Merelbeke, Belgium), YOYO-1 iodide (1 mM in DMSO) was added to the plasmid at a mixing ratio of 0.15:1 (v:w), resulting in a theoretical labeling density of 1 YOYO-dye molecule per 10 base pairs. The mixture was incubated at room temperature for 4 h in the dark. To remove the DMSO and free YOYO-1, the labeled plasmid was purified with ethanol precipitation and the fluorescently labeled plasmid was finally resuspended in 25 mM HEPES, pH 7.2. The concentration of the plasmid was again determined by UV absorption at 260 nm, and adjusted to 1 μg/μL.
Conjugation of DOPE to hyaluronic acid
The HA-DOPE conjugate was synthesized as reported by Surace et al. (Surace et al., 2009 ) based on a modified reaction described by Yerushalmi and Margalit (Yerushalmi and Margalit, 1998) . In brief, HA was dissolved in water overnight and preactivated for 2 h at 37°C by incubation with EDC at pH 4, which was adjusted by titration with 0.1 N HCl. Afterwards, DOPE suspension was added to the HA solution and pH was adjusted to 8.6 with 0.1 M borate buffer. The reaction was allowed to proceed for 24 h at 37°C. The conjugate was purified by ultrafiltration using a membrane with a molecular weight cut-off of 100,000 Da (Amicon Ultrafiltration, Millipore, Billerica, MA). Purity of the conjugate was proven by thin layer chromatography. The successful conjugation was shown by 1 H NMR. The conjugate was lyophilized and stored at −25°C until further use. The coupling degree was determined to be 1.081% w/w (weight DOPE/weight conjugate).
Liposomes and lipoplexes
To prepare uncoated liposomes, a thin lipid film was obtained by evaporation under vacuum of a chloroformic solution of an equimolar mixture of DOTAP and DOPE using a rotary vacuum evaporator. This lipid film was rehydrated with 1 mL pure ethanol, for a final molar concentration of 15 mM, and liposomes were further prepared via the ethanol injection method published by Nascimento et al. (Nascimento et al., 2015) . For liposome preparation, 400 μL of ethanolic lipid solution was rapidly injected into 2.6 mL MilliQ water under stirring with a magnetic bar to obtain a final lipid concentration of 2 mM. HA-modified liposomes were prepared by diluting an aqueous stock solution of the HA-DOPE conjugate (1 mg/mL) to different concentrations in MilliQ water before injection of the ethanol-lipid mixture. The content of HA-DOPE conjugate is expressed in percentage molar ratio HA-DOPE/ DOTAP lipids (Table 1) . For the removal of ethanol, liposome suspensions were dialyzed against distilled water overnight in Slide-A-Lyzer dialysis cassettes with a molecular weight cutoff of 10,000 (Thermo Fisher Scientific, Inc., Rockford, IL). Hydrodynamic diameter (intensity-weighted Z-average), polydispersity index (PDI) and zeta potential (ZP) were measured by dynamic light scattering with a NanoZS Zetasizer (Malvern Instruments, Hoeilaart, Belgium). All samples were measured in triplicate, diluted in 25 mM HEPES buffer pH 7.2. The size and zeta potential results for the liposomes can be found in Table 1 .
For the preparation of uncoated and PEGylated lipoplexes, a diluted pDNA solution was added to a liposome solution in HEPES buffer at an N/P ratio of 4/1, as described previously (Peeters et al., 2005) , with N representing the number of the positive charges (originating from DOTAP) and P the number of the negative charges (originating from the pDNA). This mixture was vortexed for 10 s and left to stabilize at room temperature for 15 min to allow complexation.
To prepare lipoplexes with a covalent HA-coating ( Fig. 1 right) , a similar protocol was applied where pDNA was added to HA-coated liposomes, while maintaining the N/P ratio of 4/1. Given the concentrations of HA in each liposomes, the resulting lipoplexes had N/P/C ratios ranging from 4/1/0 (uncoated lipoplexes) to 4/1/8 (200 mol% HA-liposomes), where C represent the number of negative charges originating from the carboxyl-group of the HA-monomer. For the preparation of electrostatically coated HA-lipoplexes, uncoated lipoplexes with the standard 4/1 ratio were prepared. After 15 min stabilization, HA diluted in HEPES was added to the lipoplexes corresponding to the previously mentioned N/P/C ratios. These were vortexed for 10 s and left to stabilize at room temperature for 15 min to allow complexation ( Fig. 1 left) .
Gel electrophoresis
Lipoplexes corresponding to 50 ng pDNA were prepared as previously described, after which 5 μL of Ambion loading buffer (Ambion, Merelbeke, Belgium) was added to the suspension. The mixture was loaded on a 1% agarose gel in 1× TBE buffer, to which GelRed (Biotium, Hayward, CA) was added for visualization of the pDNA. The gel was run for 40 min at 100 V and imaged.
Cell culture
ARPE-19 cells (retinal pigment epithelial cell line; ATCC number CRL-2302) were cultured in Dulbecco's modified Eagle's medium supplemented with nutrient mixture F12 (DMEM:F12 (1:1), 10% FBS, 2 mM L-glutamine and 50 μg/mL penicillin/streptomycin). Cells were incubated at 37°C in a humidified atmosphere containing 5% CO 2 and subcultured every 3 to 4 days. Cellular experiments were performed on cells in culture with passage number below 20.
Uptake and transfection efficiency
ARPE-19 cells were plated in 24 well plates at 45000 cells/well and allowed to grow overnight. For uptake studies, lipoplexes were prepared the next day with YOYO1-labeled pGL4.13 plasmids as described above, added to the cells in serum-free OptiMEM™ at a concentration of 1 μg pDNA/45,000 cells, and incubated for 2 h at 37°C in an incubator. As a negative control, ARPE-19 cells were pre-incubated on ice for 1 h, and also incubated with the particles on ice. After incubation, the particles were removed and ice-cold Trypan Blue was added to each well to quench extracellular fluorescence from lipoplexes attached to the cell membrane. After removal of Trypan Blue, the cells were washed with DBPS, trypsinized and the green YOYO1-fluorescence from the plasmids in the cell interior was measured by flow cytometry (FACSCalibur™, BD Biosciences Benelux N.V., Erembodegem, Belgium).
For transfection experiments, cells were plated similar to the uptake experiments. The next day, lipoplexes were prepared with gwiz-GFP plasmid to measure transfection efficiency and pGL4.13 plasmid as a negative control, since luciferase expression does not produce a detectable fluorescence signal in GFP-emission spectrum. Incubation of the cells was performed similar to the uptake experiments, where 1 μg pDNA was added to each well and incubated for 2 h at 37°C. Afterwards, the particles were removed, cells were washed with DPBS and fresh cell culture medium was added for 22 h incubation. 24 h after the particles were added, the cells were trypsinized and GFP expression was examined by flow cytometry.
Flow cytometry
After inhibition of trypsinization by cell culture medium, cells were centrifuged for 7 min at 300g and supernatant was removed. Cells were resuspended in flow buffer (DPBS/0,1% sodium azide/1% bovine serum albumin) and cell-associated fluorescence was analysed with a FACS Calibur (BecktonDickinson, Erembodegem, Belgium) equipped with an Argon laser (excitation 488 nm). For quantification, all experiments were performed in triplicate and for each sample, data was collected for 30 s consisting of side scatter, forward scatter and fluorescence emission of YOYO-1 dye (uptake experiments) or GFP (transfection experiments) with a 530/30 nm bandpass filter (FL1). Cellquest software (Beckton Dickinson, Erembodegem, Belgium) was used for analysis. Appropriate gating was applied to the forward/sidescatterplot of untreated cells to select for intact cells. A cell was considered positive for YOYO-1 or GFP fluorescence, if the average Table 1 Composition and physical characterization of the different liposomes evaluated in this study. Z-average size and zeta potential were measured in HEPES buffer by dynamic light scattering. Shown are average values and standard deviations of three measurements. It should be emphasized that these data concern the liposomes, without pDNA complexed. Therefore, no distinction can be made as to the electrostatic or covalent coupling of HA to the lipoplexes. fluorescence was above the threshold T, defined as the 99.5 percentile of the negative control sample.
Cytotoxicity
Cytotoxicity of the lipoplexes was evaluated with an MTT assay. ARPE-19 cells were plated in 24 well plates at 45,000 cells per well. Similar to the transfection protocol, pGL4.13-lipoplexes, prepared as previously described, were added to the cells in serum-free OptiMEM™ and incubated for 2 h at 37°C. After removal of the particles, fresh cell culture medium was added to the cells and 22 h afterwards, MTT reagent (with a final concentration of 1 mg/mL) was added to full cell culture medium for 4 h at 37°C. Finally, cells were washed and lysed with DMSO for 15 min on a shaker. Then, absorbance at 590 nm and 690 nm is measured with a plate spectrophotometer (PerkinElmer 2104 EnVision®), where A 590 relates to the metabolic activity, and A 690 is used as a reference wavelength.
Statistical analysis
Statistical tests were performed in IBM® SPSS® Statistics version 22. Normality of all triplicates was verified with a Shapiro-Wilks test. Average values were further compared by means of an independent samples t-test or Welch's t-test, based on the outcome of the Equality of Variances Levene test. The mean difference was considered significant at the p b 0.05 level.
Ex vivo evaluation of intravitreal lipoplex mobility by single particle tracking microscopy
Intravitreal mobility of nanoparticles in vitreous humor was evaluated with single particle tracking microscopy in an ex vivo model as previously described . In short, fresh bovine eyes were obtained from a local slaughterhouse, subsequently disposed of extraocular material and incised along the limbus. Then, the cornea and lens were removed, exposing the anterior part of the hyaloid membrane that holds the vitreous body. For all vitreous experiments, the sclera was punctured laterally with a 21 G guard needle (BD Microlance, BD Biosciences Benelux N.V., Erembodegem, Belgium), after which 10-20 μL of nanoparticle suspension was injected in the vitreous humor with the help of a syringe and 25 G spinal needle (BD Microlance, BD Biosciences Benelux N.V., Erembodegem, Belgium). A MatTek glass bottom dish (35 mm, No. 1.5, MatTek Corporation, MA, USA) was positioned against the hyaloid membrane, thus permitting visualization by fluorescence microscopy within the vitreous humor. The nanoparticles were injected as close as possible to the anterior hyaloid membrane and coverslip to allow visualization within the working distance of the objective lens, though far enough to avoid punctuation of the anterior hyaloid membrane and subsequent outflow of vitreous liquid. Finally, to avoid drift of the eye inside the glass bottom dish, the eye was gently fixed with parafilm. Next, the sample was stored overnight at room temperature before performing the microscopy experiments, thus allowing the nanoparticles to diffuse from the injection site into the surrounding vitreous and within the working range of the objective lens. We have previously observed that the needle used for injection disrupts the fragile vitreal network and forms a cone-like structure . Nanoparticles were therefore left overnight to diffuse in the surrounding vitreous so that diffusion measurements are performed on nanoparticles in unaffected parts of the vitreous. The microscope was always focused at 5 to 10 μm above the cover slip and for each sample, typically 20 movies of 250 frames each were recorded at different locations within the sample, at a frame rate of 31 fps. All fluorescence video imaging of diffusing nanoparticles was performed on a custombuilt laser wide field fluorescence microscope setup. Diffusion analysis of the videos was performed off-line using in-house developed software, as described before (Braeckmans et al., 2010) , providing a distribution of apparent diffusion coefficients. For a more detailed description of both the SPT microscope and the trajectory analysis, the reader is referred elsewhere .
Results
Characterization of HA-coated lipoplexes
Lipoplexes are composed of anionic pDNA and cationic DOTAP:DOPE liposomes at various molar ratios, with a final layer of anionic HA that is provided as an electrostatic or covalent coating onto the nanoparticle. Uncoated and PEGylated DOTAP:DOPE lipoplexes are also included for comparison at a N/P ratio of 4. Z-average size, polydispersity index and zeta potential of gene lipoplexes is determined with dynamic light scattering (Table 2 and Fig. 2 ). Uncoated lipoplexes are rather monodisperse (PDI b 0.3) nanoparticles with a net cationic surface charge. PEGylated lipoplexes have a similar size, while being more monodisperse (PDI = 0.113) and with a more neutral zeta potential due to the shielding of the surface charge by the PEG-chains. Uponcoating the cationic lipoplexes with HA, the surface charge of lipoplexes inverts from a positive to a negative charge upon increasing HA-content. Aggregation is observed when the zeta potential becomes near neutral.
To verify the complexation efficiency of the HA-coated lipoplexes compared to uncoated lipoplexes, the samples were loaded on a 1% agarose gel (Fig. 3) . Upon preparing electrostatically coated HA-lipoplexes, no significant decrease in complexation efficiency was noted. For the covalent HA-coated lipoplexes, on the other hand, pDNA complexation appears to be insufficient at those N/P/C-ratios where the HA-coated lipoplexes are not yet colloidally stable (judged by the increased size and PDI for 4/1/4-ratios). A bright fluorescent band is visible below the wells, where only little fluorescence is noticeable within the wells. Upon increasing HA-content, pDNA complexation efficiency increases (increase in fluorescence within the well and less fluorescence in the band with free pDNA).
Intravitreal mobility
From the characterization results obtained by DLS and gel electrophoresis, we opted to continue with covalent and electrostatic HA- coated lipoplexes with an N/P/C-ratio of 4/1/8 for the following experiments. To evaluate if HA-coating would prevent immobilization in the vitreal matrix, we determined their intravitreal mobility with our previously optimized ex vivo eye model . This model is based on excised bovine eyes from which the anterior segment is removed. By placing a cover slip in the exposed anterior hyaloid membrane, an optical window is created allowing us to visualize movement of nanoparticles in intact vitreous. By using high-resolution fluorescence microscopy and single particle tracking analysis, the intravitreal diffusional mobility profile of a nanoparticle population can be accurately measured. Fig. 4 shows the distributions of diffusion coefficients of lipoplexes in the vitreous humor as measured by SPT. First of all, it can be seen that uncoated, cationic lipoplexes show a bimodal diffusion behavior, indicative of a large immobilized fraction. A PEGylation degree of 5% greatly diminishes this immobilization, resulting in a large population of mobile lipoplexes. Also electrostatic and covalent HAcoating of lipoplexes both show a significant mobility improvement, with covalently coupled HA-lipoplexes giving the best result, likely due to the coating being more stable upon injection into the vitreous humor.
Uptake and transfection efficiency
Having determined that both electrostatic and covalent HA-coupling to lipoplexes results in improved intravitreal mobility, it now has to be verified that these nanoparticles can be taken up and transfect retinal target cells. Uptake and transfection efficiencies were determined in vitro in an ARPE-19 cell line with flow cytometry. In terms of uptake of YOYO1-labeled lipoplexes (Fig. 5A-B) , we notice that covalently coated HA-lipoplexes are taken up most efficiently, followed by electrostatic HA-lipoplexes which are taken up to the same extent as uncoated lipoplexes. PEGylation, however, results in significantly less uptake. Interesting to note are the differences in transfection efficiency between the different HA-coated lipoplexes, evaluated by the average amount of GFP expression in the ARPE-19 cell population (Fig. 5C-D) . First of all, we confirmed that a 5% PEGylation degree significantly decreases the transfection potential of the lipoplexes, resulting in almost no transgene expression. When using an electrostatic coating of HA, no significant differences in transfection efficiency are noted compared to the uncoated lipoplexes, in line with the uptake results (Fig. 5D) . Remarkably, a covalent coating with HA shows a marked eight-fold increase in transgene expression as compared to uncoated lipoplexes (Fig. 5C) . Finally, cytotoxicity of all lipoplexes was evaluated with an MTT assay (Fig. 5E) , from which can be concluded that, even though covalently coupled HA-lipoplexes appear to be slightly more cytotoxic, the HAlipoplexes are well tolerated by ARPE-19 cells. Taken together we conclude that covalent HA coating of lipoplexes outperforms electrostatic coating, both in terms of intravitreal mobility as its inherent capacity to stimulate its own uptake and transfect ARPE-19 cells.
Discussion
As retinal gene therapy is advancing in several clinical trials, clinical application might soon become reality. Yet, questions have been raised about the feasibility on a larger scale using current methodologies based on subretinal injection of viral vectors. While intravitreal injection of non-viral gene nanoparticles promises to be less costly and invasive, their therapeutic efficacy to date remains rather low. This can be attributed to the low expression of the transgene in the target cells, though efficient delivery to these target cells after intravitreal injection also poses a major problem. We have previously determined that cationic and hydrophobic surfaces are detrimental to intravitreal mobility of nanoparticles . By using a PEG-coating, we have shown that nanoparticle mobility in the vitreal matrix can be drastically improved. However, as it is known that PEGylation also decreases cellular interactions and, therefore, uptake and transfection (Mishra et al., 2004; Sanders et al., 2007) , we have recently proposed HA as an alternative coating strategy for improved intravitreal mobility while retaining the ability to transfect retinal target cells (Martens et al., 2015) . There has been a recent surge in the use of HA in the field of drug delivery due to its inherent biocompatibility and versatile nature (Yadav et al., 2008) . There is still an ongoing debate on whether the MW of HA plays a role in the targeting affinity towards hyaladherins (Raemdonck et al., 2013) , where some postulate that targeting and uptake efficacy of HA-coated nanoparticles towards CD44-expressing cell types is dependent on the MW of HA (Dufaÿ Wojcicki et al., 2012; Mizrahy et al., 2011) , while others have found no such influence of the MW on in vitro uptake and transfection efficiency of solid lipid nanoparticles (Ruiz De Garibay et al., 2015) . Interestingly, another important factor for CD44 affinity besides MW, has been thought to be grafting density (Qhattal and Liu, 2011) , where it is reasoned that the differences in CD44 affinity is due to the way free HA monomers are presented to the hyaladherins. The manner in which HA is coupled to the nanoparticle surface could therefore have an effect on the affinity towards hyaladherins.
In our study, two different approaches of coating lipoplexes with HA were compared in terms of their suitability for intravitreal injection (Fig. 1) . In the first method, increasing amounts of HA was electrostatically complexed on pre-formed cationic lipoplexes until a negative surface charge was obtained, indicating successful surface decoration with HA. This is a similar approach as in our previous study where we have electrostatically coated DNA polyplexes with HA (Martens et al., 2015) . The second approach entails the random covalent conjugation of DOPE-lipids on the HA polymer, after which liposomes will be formed with an HA-coating attached via insertion of the conjugated DOPE-lipids Fig. 3 . Gel electrophoresis showing complexation efficiency of HA-coated lipoplexes. For higher N/P/C-ratios, the covalent HA-coated lipoplexes are slightly less efficient at retaining the pDNA up to an N/P/C-ratio of 4/1/4 (evident from decreased fluorescence in the well and increased fluorescence in the lower band). Nonetheless, a higher complexation efficiency is seen for the covalent 4/1/8 ratio. in the lipid membrane. Covalently coated HA-lipoplexes were formed by complexing nucleic acids with these HA-coated liposomes. By increasing the amount of HA added to the lipoplexes, we determined that both approaches delivered nanosized, monodisperse HA-coated lipoplexes with an anionic surface charge (Fig. 2) and capable of incorporating the plasmid DNA (Fig. 3) .
The first barriers nanoparticles will encounter after intravitreal injection is the vitreous humor itself. We have previously shown that PEGylation could drastically increase the mobility of CBA-ABOL polyplexes and DOTAP:DOPE lipoplexes in the vitreous humor Peeters et al., 2005) . We further showed that an electrostatic coating of HA on these CBA-ABOL polyplexes also improved intravitreal mobility, especially for HA with low molecular weight (22 kDa and 137 kDa) (Martens et al., 2015) . In line with these results, in the present study we have found that HA-lipoplexes had markedly increased intravitreal mobility compared to the uncoated lipoplexes. Interesting to note is the bimodal mobility pattern observed for the uncoated lipoplexes, with a large immobilized fraction and a smaller mobile fraction. This is similar to what we have observed before for polyplexes and is likely due to spontaneous electrostatic coating of the lipoplexes with native vitreal HA upon injection. This is supported by the observation that this mobile fraction coincides with the mobile fraction of the electrostatically coated lipoplexes. Nonetheless, covalently coated lipoplexes were slightly more mobile than electrostatically coated ones in the vitreous, approaching the mobility of PEGylated lipoplexes (Fig. 4) .
We subsequently investigated whether the HA-lipoplexes maintained their ability to transfect retinal target cells compared to uncoated and PEGylated lipoplexes. In this study, ARPE-19 cells were used to verify in vitro uptake and transfection efficiency by flow cytometry (Fig. 5) . Whereas PEGylation decreased uptake of lipoplexes, electrostatic HAcoated lipoplexes at a 4/1/8-ratio were taken up to the same extent, and covalently coated HA lipoplexes even more than uncoated ones. More importantly, the transgene expression in ARPE-19 cells was nearly eight-fold higher for covalent HA-lipoplexes compared to the uncoated lipoplexes (Fig. 5C ). Electrostatic HA-lipoplexes, on the other hand, had the same transgene expression as uncoated ones (Fig. 5D) . We conclude from these experiments that a covalent coupling of HA to the lipoplexes appears to be most beneficial for cellular uptake and subsequent transgene expression. Our results show that the method of HA attachment has a profound influence on the efficacy of HA-coated nanomedicines. Our findings are supported by data from Toriyabe and colleagues (Toriyabe et al., 2011) , who noticed that HA-coated liposomes targeted to liver endothelial cells only accumulated at the target site when the HA was covalently attached to the surface of the liposomes, and not when it was present as an electrostatic coating.
These differences between electrostatic and covalent coating could be related to the way that HA monomers are presented to the HA-receptors. Avidity of HA to hyaladherins is dependent on multivalent interactions and several HA-monomers should be available, estimated between 20 and 38, for optimal avidity through divalent binding (Lesley, 2000) . Decreased affinity, and possibly decreased cellular uptake, has been proposed to result from a decrease in the degree of freedom the HA molecule experiences when attached to the surface of nanoparticles, thus limiting the amount of potential reaction sites available for binding to the hyaladherins (Mizrahy et al., 2011) . Alternatively, the electrostatic coating might be less stable in the complex media used for cell culture, leading to HA polymers detaching from the previously stable nanoparticle. This in turn could result in free HA polymers in the cell culture media competing for the binding sites at cellular hyaladherins, and thus limiting cellular uptake of electrostatic HAlipoplexes. Covalent HA-lipoplexes, on the other hand, have HA polymers covalently attached to the nanoparticle surface and will be less likely to rearrange in complex media or have HA polymers detaching from the nanoparticle surface. Therefore, it is less likely to have free HA polymers in the cell culture media competing with binding sites of the cellular hyaladherins. Considering the putative differences in avidity between electrostatic and covalent HA-lipoplexes, and even though uptake of covalent HA-lipoplexes is noticeably higher than that of the electrostatic counterparts, it may not solely account for the eight-fold increase in transgene expression. It could be that the differences in HA presentation and hyaladherins avidity bring about a different entry pathway, and a more efficient subsequent intracellular processing. Indeed, it is a well-known fact that efficiency in transgene expression is not exclusively determined by the amount of cellular uptake, but that different intracellular barriers have to be overcome such as endosomal escape (Martens et al., 2014; Vercauteren et al., 2012) . Early studies by Ruponen et al. document the influence of extracellular GAGs on transfection efficiency of different non-viral drug delivery systems on smooth muscle cells from rabbit aortic media (Ruponen et al., 2001 (Ruponen et al., , 1999 . They conclude that differences in transfection efficiency cannot be solely attributed to cellular uptake, and hypothesize that alternative intracellular pathways are likely activated based on the GAGs. Contreras-Ruiz et al. also hypothesized in their study that HA influences the uptake pathway and intracellular processing, bypassing the lysosomal pathway and therefore avoiding degradation (Contreras-Ruiz et al., 2011) . It could be argued that different coating strategies, and therefore different ways of presenting HA monomers to hyaladherins, would result in different uptake pathways depending on said coating strategies. These are aspects that may be the topic of future studies.
Additionally, it is of note that in vivo, the RPE cell layer is a highly differentiated cell layer with apicobasal structure. Such differentiation could also bring about changes in extracellular protein expression, with differences in targeting avidity or efficiency for certain ligands. As such, it is of interest to investigate in future studies, the effects of the intracellular processing in differentiated ARPE-19 cells or primary RPE's.
An important aspect that should be kept in mind, is the ability of gene nanotherapeutics to cross the vitreoretinal barrier and permeate the retina towards the RPE cell layer after intravitreal injection. Indeed, the inner limiting membrane is considered to be a potential barrier for nanoparticle penetration in the retina from the vitreous (Dalkara et al., 2009; Puras et al., 2013 ). Gan and colleagues have shown that coreshell liponanoparticles covalently modified with HA were able to cross the ILM and penetrate the retina (Gan et al., 2013) . However they only observed this effect in an experimental autoimmune uveitis model, while in healthy retinas, the authors found that the nanoparticles remain trapped at the ILM, even up to 7 days after intravitreal injection. A similar observation was made by Iezzi et al. for uncoated poly(amido amine) dendrimers (Iezzi et al., 2012) . Nevertheless, some studies do show intravitreally injected nanoparticles overcoming the ILM barrier and penetrating into the healthy retina (Bejjani et al., 2005; Bourges et al., 2003; Kim et al., 2009) . Most notably, self-assembled amphiphilic polymeric nanoparticles with a 5β-cholanic core and HA-shell were shown to efficiently penetrate the healthy retina of rats 6 h and 24 h after intravitreal injection (Koo et al., 2012) . The authors further postulated that intravitreal nanoparticles (either with HA-shell or human serum albumin) crossed the ILM by endocytosis in the Müller cells, based on previously published results from this group with human serum albumin-based nanoparticles (Kim et al., 2009) . Taken together these variable findings show that further research on this issue is needed, including for the HA coated liposomes presented in this study.
Conclusion
In conclusion, we document the differences in behavior of two different approaches for HA-coating of lipoplexes intended for retinal gene therapy via intravitreal administration. HA-lipoplexes were prepared either by an electrostatic attachment of HA to preformed lipoplexes, or by the formation of HA-liposomes using a preformed HA-DOPE conjugate. Both approaches resulted in anionic, monodisperse HA-lipoplexes at an N/P/C-ratio of 4/1/8, which markedly improved their intravitreal mobility compared to uncoated lipoplexes in an ex vivo vitreal model. Furthermore, we noticed that the HA-lipoplexes were very well tolerated in vitro and that transfection efficiency in ARPE-19 cells was not hampered by the HA-coating. On the contrary, a covalent HA-coating provided an eight-fold increase in transgene expression compared to the uncoated and electrostatically coated cationic lipoplexes. Taken together, our data suggest that a covalent coupling of HA to lipoplexes is a promising avenue for gene nanomedicines.
